Pages that link to "Q47665833"
Jump to navigation
Jump to search
The following pages link to Prevalence of AD among whites: a summary by levels of severity (Q47665833):
Displaying 50 items.
- Forecasting the global burden of Alzheimer’s disease (Q22252403) (← links)
- Challenges in surveillance of dementias in New York State (Q24800633) (← links)
- Traumatic brain injury as a risk factor for Alzheimer disease. Comparison of two retrospective autopsy cohorts with evaluation of ApoE genotype (Q24802281) (← links)
- A Unified Hypothesis of Early- and Late-Onset Alzheimer's Disease Pathogenesis (Q26781496) (← links)
- Alzheimer's disease, oestrogen and mitochondria: an ambiguous relationship (Q26865759) (← links)
- Genetic of Alzheimer's Disease: A Narrative Review Article (Q27007467) (← links)
- Ethical, and practical issues in applying functional imaging to the clinical management of Alzheimer's disease (Q30754957) (← links)
- Prospects for prediction: ethics analysis of neuroimaging in Alzheimer's disease (Q31108301) (← links)
- Identification of dementia: agreement among national survey data, medicare claims, and death certificates (Q31143408) (← links)
- Gender- and age-dependent gamma-secretase activity in mouse brain and its implication in sporadic Alzheimer disease (Q33427814) (← links)
- Promoting successful cognitive aging: a comprehensive review (Q33544151) (← links)
- Estrogen and hippocampal plasticity in rodent models (Q33644111) (← links)
- Non-feminizing estrogens: a novel neuroprotective therapy (Q33693293) (← links)
- Brain estrogen deficiency accelerates Abeta plaque formation in an Alzheimer's disease animal model (Q34244907) (← links)
- Sex- and brain region-specific acceleration of β-amyloidogenesis following behavioral stress in a mouse model of Alzheimer's disease. (Q34332342) (← links)
- Single photon emission CT and positron emission tomography in the evaluation of neurologic disease (Q34391742) (← links)
- Involvement of oxidative stress in Alzheimer disease (Q34545547) (← links)
- Neuropsychological differences between frontotemporal dementia and Alzheimer's disease: a review. (Q34563065) (← links)
- Aβ reduction in BACE1 heterozygous null 5XFAD mice is associated with transgenic APP level (Q34979085) (← links)
- Essentials of the Proper Diagnoses of Mild Cognitive Impairment, Dementia, and Major Subtypes of Dementia (Q35553096) (← links)
- Effects of aromatase inhibition versus gonadectomy on hippocampal complex amyloid pathology in triple transgenic mice (Q35577375) (← links)
- Polyphenols and human health: prevention of disease and mechanisms of action (Q35670850) (← links)
- The association of antidepressant drug usage with cognitive impairment or dementia, including Alzheimer disease: A systematic review and meta-analysis (Q36234470) (← links)
- Protease inhibitors as potential disease-modifying therapeutics for Alzheimer's disease (Q36300032) (← links)
- Hypothalamic-pituitary-gonadal axis homeostasis predicts longevity (Q36528233) (← links)
- Galantamine extended release in Alzheimer's disease: profile report (Q36635479) (← links)
- Mild Cognitive Impairment and Dementia Prevalence: The Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS). (Q36635828) (← links)
- Alzheimer's disease and genetics of inflammation: a pharmacogenomic vision (Q37034397) (← links)
- Number of children is associated with neuropathology of Alzheimer's disease in women (Q37283496) (← links)
- Novel regimens and delivery systems in the pharmacological treatment of Alzheimer's disease (Q37448875) (← links)
- Molecular pathogenesis of Alzheimer's disease: reductionist versus expansionist approaches (Q37462278) (← links)
- Amyloid precursor protein mutation disrupts reproductive experience-enhanced normal cognitive development in a mouse model of Alzheimer's disease (Q37479186) (← links)
- Galantamine-ER for the treatment of mild-to-moderate Alzheimer's disease. (Q37695074) (← links)
- Memantine ER, a once-daily formulation for the treatment of Alzheimer's disease (Q37764347) (← links)
- Psychosocial interventions in Alzheimer's disease and amnestic mild cognitive impairment: evidence for gender bias in clinical trials (Q38232453) (← links)
- Bioavailability, bioactivity and impact on health of dietary flavonoids and related compounds: an update (Q38245598) (← links)
- Effects of closed traumatic brain injury and genetic factors on the development of Alzheimer's disease. (Q38458256) (← links)
- Genetic Polymorphisms in Estrogen Metabolic Pathway Associated with Risks of Alzheimer's Disease: Evidence from a Southern Chinese Population. (Q39012622) (← links)
- Prevalence of dementia among Veterans Affairs medical care system users. (Q39130949) (← links)
- Noggin Along with a Self-Assembling Peptide Nanofiber Containing Long Motif of Laminin Induces Tyrosine Hydroxylase Gene Expression (Q42495903) (← links)
- Risk of Alzheimer's disease in relation to diabetes: a population-based cohort study. (Q44613096) (← links)
- Variations in case definition affect prevalence but not outcomes of mild cognitive impairment (Q44922548) (← links)
- Impaired performance of female APP/PS1 mice in the Morris water maze is coupled with increased Aβ accumulation and microglial activation (Q46234268) (← links)
- Cognitive, functional and behavioral assessment: Alzheimer's disease. (Q46907896) (← links)
- Is large-scale community memory screening feasible? Experience from a regional memory-screening day. (Q47725169) (← links)
- Oligomeric Abeta in Alzheimer's disease: relationship to plaque and tangle pathology, APOE genotype and cerebral amyloid angiopathy (Q48469261) (← links)
- Loss of GPR3 reduces the amyloid plaque burden and improves memory in Alzheimer's disease mouse models (Q50702084) (← links)
- Confrontation naming does not add incremental diagnostic utility in MCI and Alzheimer's disease (Q50747975) (← links)
- Galantamine extended release (Q51914477) (← links)
- Dementia in subjects aged 75 years or over within the PAQUID cohort: prevalence and burden by severity (Q51917258) (← links)